Literature DB >> 33307265

The Effects of Bispectral Index-Guided Anesthesia on Postoperative Delirium in Elderly Patients: A Systematic Review and Meta-Analysis.

Weifeng Shan1, Bingquan Chen2, Linger Huang2, Yanfeng Zhou2.   

Abstract

OBJECTIVE: Postoperative delirium (POD) is a form of delirium that affects patients who have undergone surgical procedures and anesthesia, usually peaking between 1 and 3 days after their operation. The aim of this meta-analysis was to determine whether monitoring of depth of anesthesia may influence the incidence of POD.
METHODS: A systematic literature search was conducted on studies that reported POD in elderly patients (>60 years old) who underwent surgery. This meta-analysis was carried out using random-effects model.
RESULTS: Compared with control group, intraoperative bispectral index (BIS) monitoring reduced POD (odds ratio 1.32, 95% confidence interval 1.11-1.57, P = 0.001, I2 = 51%). In the mixed-surgery group, compared with the control group, BIS monitoring decreased the incidence of POD (odds ratio 1.24, 95% confidence interval 1.07-1.44, P = 0.004, I2 = 61%). There was also no significant difference in the incidence of POD among patients who underwent cardiac, colon, and orthopedic surgeries.
CONCLUSIONS: BIS monitoring during surgery can reduce the incidence of POD in elderly patients. Whether BIS monitoring may reduce the incidence of POD in a single type of surgery needs further study.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bispectral index; Elderly patients; Major surgery; Postoperative delirium

Year:  2020        PMID: 33307265     DOI: 10.1016/j.wneu.2020.11.110

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  Neuromonitoring depth of anesthesia and its association with postoperative delirium.

Authors:  Berta Pérez-Otal; Cristian Aragón-Benedí; Ana Pascual-Bellosta; Sonia Ortega-Lucea; Javier Martínez-Ubieto; J M Ramírez-Rodríguez
Journal:  Sci Rep       Date:  2022-07-26       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.